Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.

doi:10.1093/cid/cir669

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Back to search

Article

Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Dec 2011

Scherrer Alexandra U, Ledergerber Bruno, von Wyl Viktor, Böni Jürg, Yerly Sabine, Klimkait Thomas, Bürgisser Philippe, Rauch Andri, Hirschel Bernard, Cavassini Matthias, Elzi Luigia, Vernazza Pietro L, Bernasconi Enos, Held Leonhard, Günthard Huldrych F

Abstract excerpt

BACKGROUND: Antiretroviral compounds have been predominantly studied in human immunodeficiency virus type 1 (HIV-1) subtype B, but only ~10% of infections worldwide are caused by this subtype. The analysis of the impact of different HIV subtypes on treatment outcome is important. METHODS: The effect of HIV-1 subtype B and non-B on the time to virological failure while taking combination antiretroviral therapy...

Topics

Adult
Aged
Anti-HIV Agents
Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
Cohort Studies
Female
Genotype
HIV Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

HIV-1

Humans

Male

Middle Aged

Switzerland

Treatment Outcome

Viral Load

White People

Source

Open in PubMed

Identifiers

PMID: 21998284
DOI: 10.1093/cid/cir669

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.PMID 21998284Read ↗

Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review.Semantic proximity Read ↗

Drug resistance in non-subtype B HIV-1.Semantic proximity Read ↗

Effect of HIV type 1 subtype on virological and immunological response to combination antiretroviral therapy: evidence for a more rapid viral suppression for subtype A than subtype B-infected Greek individuals.Semantic proximity Read ↗

Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.Semantic proximity Read ↗

Does genetic diversity of HIV-1 non-B subtypes differentially impact disease progression in treatment-naive HIV-1-infected individuals? A systematic review of evidence: 1996-2010.Semantic proximity Read ↗

HIV-1 subtype B/B' and baseline drug resistance mutation are associated with virologic failure: a multicenter cohort study in China.Semantic proximity Read ↗

Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis.Semantic proximity Read ↗

The impact of HIV-1 subtype on the clinical response on HAART.Semantic proximity Read ↗

Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes.Semantic proximity Read ↗

Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.Semantic proximity Read ↗

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.Semantic proximity Read ↗

Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.